NGD CEO Paul Rhodes Announces Publication in the Journal of Clinical Microbiology Validating Machine Learning-Based Resistance Prediction

Next Gen Diagnostics, which is bringing whole genome sequencing to clinical microbiology and Vanderbilt University Medical Center announce publication in the Journal of Clinical Microbiology of a study indicating that accuracy of a machine learning model of resistance to cefepime in E. coli is greater than that of the in vitro standard of care. These results, for a clinically significant drug-species combination, add to the evidence suggesting consideration of sequence, versus in vitro tests, as the basis for selection of infection therapy.